GlaxoSmithKline announces extended asthma control therapy indication for children above a year of age.
GLAXOSMITHKLINE Pharmaceutical (GSK) recently announced an extended indication for fluticasone propionate 50mcg, a pressurised metered-dose inhaler which has a marked anti-inflammatory effect in the lungs.
Already a subscriber? Log in.
Subscribe now for a chance to win your dream holiday!
![](https://cdn.thestar.com.my/Themes/img/sub_paywall_TSM.webp)
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!